Patients Eligible for Trials of Microbe-based Therapeutics do not Represent the Population With Recurrent Clostridioides difficile Infection
Kelly, C., Fischer, M., Grinspan, A., & Allegretti, J. (2019). Patients Eligible for Trials of Microbe-based Therapeutics do not Represent the Population With Recurrent Clostridioides difficile Infection. Clinical Gastroenterology And Hepatology. doi:10.1016/j.cgh.2019.06.034